Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

AMS:PRX - Euronext Amsterdam - NL0013654783 - Common Stock - Currency: EUR

52.64  +1.89 (+3.72%)

Fundamental Rating

6

Taking everything into account, PRX scores 6 out of 10 in our fundamental rating. PRX was compared to 11 industry peers in the Broadline Retail industry. While PRX has a great health rating, its profitability is only average at the moment. PRX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year PRX was profitable.
In the past year PRX had a positive cash flow from operations.
Each year in the past 5 years PRX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

Looking at the Return On Assets, with a value of 17.04%, PRX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
The Return On Equity of PRX (24.23%) is better than 72.73% of its industry peers.
PRX has a worse Return On Invested Capital (0.21%) than 72.73% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

PRX has a better Profit Margin (200.44%) than 90.91% of its industry peers.
In the last couple of years the Profit Margin of PRX has grown nicely.
PRX's Operating Margin of 3.05% is on the low side compared to the rest of the industry. PRX is outperformed by 81.82% of its industry peers.
PRX's Gross Margin of 42.53% is on the low side compared to the rest of the industry. PRX is outperformed by 63.64% of its industry peers.
In the last couple of years the Gross Margin of PRX has grown nicely.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRX is destroying value.
PRX has less shares outstanding than it did 1 year ago.
PRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PRX has an improved debt to assets ratio.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

PRX has an Altman-Z score of 4.98. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
PRX has a better Altman-Z score (4.98) than 72.73% of its industry peers.
The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PRX (9.30) is comparable to the rest of the industry.
PRX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PRX (0.30) is better than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 4.98
ROIC/WACC0.03
WACC6.94%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 3.54 indicates that PRX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.54, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PRX has a Quick Ratio of 3.50. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.50, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

6

3. Growth

3.1 Past

PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.26%, which is quite impressive.
The Earnings Per Share has been growing by 17.24% on average over the past years. This is quite good.
PRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.86%.
PRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

Based on estimates for the next years, PRX will show a decrease in Earnings Per Share. The EPS will decrease by -6.24% on average per year.
PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.04% yearly.
EPS Next Y19.75%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
EPS Next 5YN/A
Revenue Next Year24.81%
Revenue Next 2Y16.7%
Revenue Next 3Y17.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.83, which indicates a very decent valuation of PRX.
Compared to the rest of the industry, the Price/Earnings ratio of PRX indicates a rather cheap valuation: PRX is cheaper than 90.91% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of PRX to the average of the S&P500 Index (26.73), we can say PRX is valued rather cheaply.
The Price/Forward Earnings ratio is 15.43, which indicates a correct valuation of PRX.
Based on the Price/Forward Earnings ratio, PRX is valued a bit cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.61. PRX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.83
Fwd PE 15.43
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRX indicates a rather expensive valuation: PRX more expensive than 81.82% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PRX.
Industry RankSector Rank
P/FCF 82.25
EV/EBITDA 376.01
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as PRX's earnings are expected to decrease with -6.24% in the coming years.
PEG (NY)0.6
PEG (5Y)0.69
EPS Next 2Y17.74%
EPS Next 3Y-6.24%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.20%, PRX is not a good candidate for dividend investing.
PRX's Dividend Yield is a higher than the industry average which is at 1.22.
With a Dividend Yield of 0.20, PRX pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PRX pays out 2.17% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of PRX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP2.17%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

PROSUS NV

AMS:PRX (8/13/2025, 5:36:15 PM)

52.64

+1.89 (+3.72%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)06-23 2025-06-23/amc
Earnings (Next)11-24 2025-11-24
Inst Owners63.56%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap125.23B
Analysts76.67
Price Target57.04 (8.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.24%
PT rev (3m)8.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.17%
Revenue NY rev (3m)10.93%
Valuation
Industry RankSector Rank
PE 11.83
Fwd PE 15.43
P/S 23.56
P/FCF 82.25
P/OCF 77.6
P/B 2.85
P/tB 2.94
EV/EBITDA 376.01
EPS(TTM)4.45
EY8.45%
EPS(NY)3.41
Fwd EY6.48%
FCF(TTM)0.64
FCFY1.22%
OCF(TTM)0.68
OCFY1.29%
SpS2.23
BVpS18.49
TBVpS17.93
PEG (NY)0.6
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 4.98
F-Score6
WACC6.94%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y19.75%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year24.81%
Revenue Next 2Y16.7%
Revenue Next 3Y17.04%
Revenue Next 5YN/A
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year228.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A